Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Optimal Threshold for a Positive Hybrid Capture 2 Test for Detection of Human Papillomavirus: Data from the ARTISTIC Trial

(2009) A. Sargent et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis

(2009) Renée M Overmeer et al.   JOURNAL OF PATHOLOGY

Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting

(2009) Maarit Leinonen et al.   JNCI-Journal of the National Cancer Institute

Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening

(2009) P. Naucler et al.   JNCI-Journal of the National Cancer Institute

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

(2009)   LANCET

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

(2009) Henry C Kitchener et al.   LANCET ONCOLOGY

How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands

(2009) Veerle M.H. Coupé et al.   VACCINE

Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening

(2008) Laura Kotaniemi-Talonen et al.   INTERNATIONAL JOURNAL OF CANCER

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC

(2008) RM Overmeer et al.   JOURNAL OF PATHOLOGY

Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

(2008) J. D. Goldhaber-Fiebert et al.   JNCI-Journal of the National Cancer Institute

Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test

(2008) G. Ronco et al.   JNCI-Journal of the National Cancer Institute

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

(2008) Francesca Carozzi et al.   LANCET ONCOLOGY

Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

(2008) Jack Cuzick et al.   VACCINE